We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$165B
AUM Growth
-$22.2B
Cap. Flow
-$11.2B
Cap. Flow %
-6.82%
Top 10 Hldgs %
27.67%
Holding
6,926
New
1,006
Increased
1,821
Reduced
3,025
Closed
497

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$852M
2
MSFT icon
Microsoft
MSFT
+$575M
3
CVNA icon
Carvana
CVNA
+$540M
4
TGT icon
Target
TGT
+$430M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$376M

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Financials 5.96%
3 Consumer Discretionary 5.3%
4 Healthcare 4.99%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGP icon
5926
Ultrapar
UGP
$6.71B
$2K ﹤0.01%
800
USRT icon
5927
iShares Core US REIT ETF
USRT
$4.73B
$2K ﹤0.01%
35
-28
-44% -$1.76K
XLO icon
5928
Xilio Therapeutics
XLO
$59.8M
$2K ﹤0.01%
23
-134
-85% -$21.2K
SER icon
5929
Serina Therapeutics
SER
$31.5M
$2K ﹤0.01%
+73
New +$2.08K
OKUR
5930
OnKure Therapeutics
OKUR
$164M
$2K ﹤0.01%
76
-187
-71% -$10.5K
ACHL
5931
DELISTED
Achilles Therapeutics
ACHL
$2K ﹤0.01%
844
-341
-29% -$1.21K
MVPS
5932
DELISTED
Amplify Thematic All-Stars ETF
MVPS
$2K ﹤0.01%
+76
New +$1.64K
HYZNW
5933
CALL
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$2K ﹤0.01%
1,016
VINC
5934
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2K ﹤0.01%
30
-212
-88% -$26.2K
LKCO
5935
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$2K ﹤0.01%
18
-78
-81% -$11K
COOLW
5936
CALL
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$2K ﹤0.01%
+7,634
New +$2.95K
AFIB
5937
DELISTED
Acutus Medical Inc
AFIB
$2K ﹤0.01%
1,355
-3,548
-72% -$7.59K
CHIC
5938
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$2K ﹤0.01%
100
COMS
5939
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$2K ﹤0.01%
+24
New +$1.51K
THRN
5940
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$2K ﹤0.01%
263
-2,865
-92% -$15.4K
DBTX
5941
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2K ﹤0.01%
531
-220
-29% -$843
TKAT
5942
DELISTED
Takung Art Co., Ltd.
TKAT
$2K ﹤0.01%
+700
New +$1.86K
SMFL
5943
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$2K ﹤0.01%
+1
New +$3.49K
HMPT
5944
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$2K ﹤0.01%
684
-1,091
-61% -$4.2K
FNCH
5945
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2K ﹤0.01%
11
-52
-83% -$12K
WEJO
5946
DELISTED
Wejo Group Limited Common Shares
WEJO
$2K ﹤0.01%
+600
New +$2.6K
SGTX
5947
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$2K ﹤0.01%
94
-205
-69% -$4.57K
TBSAW
5948
CALL
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$2K ﹤0.01%
+8,334
New +$3.35K
TMDI
5949
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$2K ﹤0.01%
+3,000
New +$1.74K
MTCR
5950
DELISTED
Metacrine, Inc. Common Stock
MTCR
$2K ﹤0.01%
+2,982
New +$1.56K

Similar funds

Citigroup's Q1 2022 Portfolio in Review

As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.

  • Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
  • Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
  • Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
  • Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
  • Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
  • Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.